Christian Schulze: Insights from DANGERSHOCK on Bleeding in IMPELLA Patients
Christian Schulze, Professor of Medicine at Friedrich-Schiller-University Jena, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Bleeding events in IMPELLA patients are common and prognostically relevant.
In DANGERSHOCK, bleeding was associated with the complexity of MCS, with one-half of the bleeding events occurring after device removal.”
Title: Bleeding in Patients With Infarct-Related Cardiogenic Shock: A DanGer Shock Substudy
Authors: Rikke Sørensen, Jacob Eifer Møller, Christophe Vandenbriele, Christian Hassager, Hans Eiskjær, Norman Mangner, Amin Polzin, P. Christian Schulze, Carsten Skurk, Peter Nordbeck, Peter Clemmensen, Vasileios Panoulas, Sebastian Zimmer, Andreas Schäfer, Steffen Christensen, Thomas Engstrøm, Rasmus Paulin Beske, Martin Frydland, Lisette Okkels Jensen, Anders Junker, Henrik Schmidt, Nanna Louise Junker Udesen, Christian Juhl Terkelsen, Axel Linke, Lene Holmvang, the DanGer Shock Investigators
Read the Full Article on JACC: Cardiovascular Interventions
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 5, 2026, 04:54Saneha Anjum Shaik: What Every Clinician Should Know Before Ordering Blood Tests
-
Jul 5, 2026, 04:37Mathis Richter: How The Bone Marrow Responds To Myocardial Infarction Predicts Clinical Outcome
-
Jul 5, 2026, 02:45Marie Luise Hütter-Krönke: Can a Short Course of BCMA-Targeted Therapy Induce Long-Term Remission in Refractory Autoimmune Disease?
-
Jul 5, 2026, 02:24Shreya Agarwa: Transforming Care For Adolescents With Heavy Menstrual Bleeding
-
Jul 4, 2026, 17:38Michael Stark: Greater Improvements in Cerebral Oxygenation With Restrictive Transfusion Thresholds
-
Jul 4, 2026, 17:27Reza Shojaei: How America Won the Plasma Race
-
Jul 4, 2026, 17:26Akshat Jain: The First CRISPR-Cas9 Gene Therapy Approved for Children as Young as 2 with SCD
-
Jul 4, 2026, 17:25Francesca Palandri: Dynamic, Treatment Response-Driven Risk Assessment in Polycythemia Vera
-
Jul 4, 2026, 17:24Thierry Burnouf: The Fragile Supply of Human Hyperimmune Immunoglobulins